We further established the utility of this line for the investigation of renal cancer biology by generating Slc22a6-CreERT2/Vhlfl/fl compound mice which phenocopied previously published models [24–26] and exhibited no limiting morbidity or mortality. The gene discussed is SLC22A6; the disease is renal carcinoma.